REQUEST A DEMO
Total
USD $0.00
Search more companies

Cardozo Valenzuela Luis Gabriel (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Cardozo Valenzuela Luis Gabriel Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cardozo Valenzuela Luis Gabriel is an enterprise in Colombia, with the main office in San Gil. The company operates in the Pharmacies and Drug Stores sector. It was first established on January 09, 2001. 4 (2024) employees currently work for Cardozo Valenzuela Luis Gabriel. The company’s latest financial report indicates a net sales revenue increase of 0.19% in 2023. There was a total growth of 0.87% in Cardozo Valenzuela Luis Gabriel’s total assets over the same period. In 2023, Cardozo Valenzuela Luis Gabriel’s net profit margin decreased by 9.43%.

Headquarters
Cra. 11 12-43
San Gil; Santander;

Contact Details: Purchase the Cardozo Valenzuela Luis Gabriel report to view the information.

Basic Information
Total Employees:
Purchase the Cardozo Valenzuela Luis Gabriel report to view the information.
Outstanding Shares:
Purchase the Cardozo Valenzuela Luis Gabriel report to view the information.
Incorporation Date:
January 09, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Cardozo Valenzuela Luis Gabriel report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
0.19%
Total operating revenue
0.19%
Net Profit (Loss) for the Period
-64.56%
Total assets
0.87%
Total equity
47.55%
Net Profit Margin
-9.43%
Return on Equity (ROE)
-50.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?